BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8974337)

  • 1. 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism.
    Overstreet DH; Rezvani AH; Pucilowski O; Janowsky DS
    Alcohol Alcohol Suppl; 1994; 2():205-10. PubMed ID: 8974337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
    Maurel S; Schreiber R; De Vry J
    Behav Pharmacol; 1998 Jul; 9(4):337-43. PubMed ID: 10065922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring.
    Kim JA; Gillespie RA; Druse MJ
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1169-78. PubMed ID: 9347075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption.
    Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Ogata M; Nishimura A; Yoshida T; Ueda S; Komura S
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):311A-319A. PubMed ID: 8986229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.
    Overstreet DH; Rezvani AH; Cowen M; Chen F; Lawrence AJ
    Addict Biol; 2006 Sep; 11(3-4):356-73. PubMed ID: 16961764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
    Hungund BL; Basavarajappa BS
    Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT(7) receptors in the modulation of cognitive processes.
    Cifariello A; Pompili A; Gasbarri A
    Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
    Pratt WE; Blackstone K; Connolly ME; Skelly MJ
    Behav Neurosci; 2009 Oct; 123(5):1046-57. PubMed ID: 19824770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor ligands and the treatment of obesity.
    Vickers SP; Dourish CT
    Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.
    Overstreet DH; McArthur RA; Rezvani AH; Post C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1448-54. PubMed ID: 9394117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala.
    Stein C; Davidowa H; Albrecht D
    Synapse; 2000 Dec; 38(3):328-37. PubMed ID: 11020236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.